Last updated on February 2020

A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer

Brief description of study

This study will evaluate the efficacy and safety of atezolizumab plus chemotherapy compared with placebo plus chemotherapy in patients with inoperable recurrent triple-negative breast cancer (TNBC).

Clinical Study Identifier: NCT03371017

Find a site near you

Start Over

The Valley Hospital

Paramus, NJ United States
  Connect »

Magee-Woman's Hospital

Pittsburgh, PA United States
  Connect »

Inova Schar Cancer Institute

Falls Church, VA United States
  Connect »


Villejuif, France
  Connect »

Samsung Medical Center

Seoul, Korea, Republic of
  Connect »

HCA Midwest Division

Kansas City, MO United States
  Connect »

Moscow City Oncology Hospital #62

Moscovskaya Oblast, Russian Federation
  Connect »

Richards Bay Oncology Centre

KwaZulu Natal, South Africa
  Connect »


London, United Kingdom
  Connect »

Christie Hospital NHS Trust

Manchester, United Kingdom
  Connect »

Mount Vernon Cancer Centre

Northwood, United Kingdom
  Connect »

Royal Stoke University Hospital

Stoke on Trent, United Kingdom
  Connect »